SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-023692
Filing Date
2024-06-13
Accepted
2024-06-13 16:14:29
Documents
1
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1533
  Complete submission text file 0001493152-24-023692.txt   3260
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1524 CLOVERFIELD BOULEVARD SUITE E SANTA MONICA CA 90404
Business Address
URBAN ALAN LOUIS (Reporting) CIK: 0001534376 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40023 | Film No.: 241041389